UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its stake in shares of Eastman Chemical Company (NYSE:EMN – Free Report) by 3.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 233,945 shares of the basic materials company’s stock after selling 7,534 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.20% of Eastman Chemical worth $15,670,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of the stock. Thrivent Financial for Lutherans increased its holdings in shares of Eastman Chemical by 18.1% in the 4th quarter. Thrivent Financial for Lutherans now owns 617,870 shares of the basic materials company’s stock worth $39,439,000 after purchasing an additional 94,679 shares in the last quarter. SVB Wealth LLC lifted its holdings in shares of Eastman Chemical by 108.6% during the fourth quarter. SVB Wealth LLC now owns 49,571 shares of the basic materials company’s stock valued at $3,164,000 after purchasing an additional 25,806 shares in the last quarter. Royal Bank of Canada boosted its position in shares of Eastman Chemical by 29.3% during the first quarter. Royal Bank of Canada now owns 188,049 shares of the basic materials company’s stock valued at $14,352,000 after buying an additional 42,601 shares during the last quarter. Empowered Funds LLC increased its holdings in Eastman Chemical by 270.9% in the 1st quarter. Empowered Funds LLC now owns 65,611 shares of the basic materials company’s stock worth $5,007,000 after buying an additional 47,923 shares in the last quarter. Finally, Shoker Investment Counsel Inc. purchased a new position in Eastman Chemical in the 4th quarter worth about $1,639,000. 83.65% of the stock is owned by hedge funds and other institutional investors.
Eastman Chemical Trading Up 0.5%
Eastman Chemical stock opened at $71.15 on Friday. Eastman Chemical Company has a 12-month low of $56.11 and a 12-month high of $83.47. The firm has a market capitalization of $8.14 billion, a price-to-earnings ratio of 18.53, a P/E/G ratio of 0.87 and a beta of 1.07. The firm has a 50 day moving average of $70.60 and a 200 day moving average of $72.25. The company has a current ratio of 1.50, a quick ratio of 0.76 and a debt-to-equity ratio of 0.72.
Eastman Chemical Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Shareholders of record on Tuesday, September 15th will be issued a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $3.36 dividend on an annualized basis and a yield of 4.7%. Eastman Chemical’s dividend payout ratio (DPR) is currently 87.50%.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the stock. Royal Bank Of Canada raised their price target on shares of Eastman Chemical from $69.00 to $74.00 and gave the company a “sector perform” rating in a report on Wednesday, August 5th. The Goldman Sachs Group restated a “neutral” rating and set a $75.00 price objective on shares of Eastman Chemical in a research report on Thursday, July 16th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $74.00 target price on shares of Eastman Chemical in a report on Monday, August 3rd. Citigroup decreased their target price on shares of Eastman Chemical from $85.00 to $81.00 and set a “buy” rating for the company in a research note on Monday, August 3rd. Finally, UBS Group raised their price target on Eastman Chemical from $89.00 to $92.00 and gave the stock a “buy” rating in a research note on Monday, August 3rd. Seven analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $79.17.
View Our Latest Research Report on Eastman Chemical
Eastman Chemical Company Profile
Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.
The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.
See Also
- Five stocks we like better than Eastman Chemical
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Want to see what other hedge funds are holding EMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eastman Chemical Company (NYSE:EMN – Free Report).
Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.
